The fact that there was no difference in the length of oxygen demand after plasma administration between patients receiving remdesivir and CP treatment at the same time and those receiving it separately implies that passively transferred antibodies play a key role in COVID-19 clinical recovery. Here, CP is linked to COVID-19.